Table 2 Gene sets used in this analysis
From: Evaluation of biological pathways involved in chemotherapy response in breast cancer
Functional Pathway | Number of probe sets (corresponding # of known genes) | Reference |
|---|---|---|
Cytogenetic sets (n = 319 sets) | 15-500 (variable) | Subramanian et al. [5] |
Functional sets (n = 522 sets) | 15-500 (variable) | Subramanian et al. [5] |
Oncogenic Pathways (5 sets) | Â | Bild et al. [10] |
Myc | 164 (139) | Â |
Ras | 228 (176) | Â |
E2F3 | 173 (147) | Â |
β-catenin | 54 (42) |  |
Src | 46 (44) | Â |
Genomic Grade Index (1 set) | 242 (183) | Sotiriou et al. [13] |
76-gene prognostic signature (1 set) | 76 (76) | Wang et al. [14] |
Proliferation signature (1 set) | 74 (44) | Whitfield et al. [15] |
ABC transporter gene set (1 set) | 61 (47) | Szakacs et al. [16] |
Mutant-p53 signature (1 set) | 25 (21) | Miller et al. [11] |
ER-associated gene set (1 set) | 200 (187) | Symmans et al. [12] |